Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Clinical Rheumatology|March 21, 2021
B cells in systemic sclerosis: from pathophysiology to treatmentKonstantinos Melissaropoulos, Dimitrios Daoussis
Rheumatology International|June 6, 2018
Decreased CD22 expression and intracellular signaling aberrations in B cells of patients with systemic sclerosisKonstantinos Melissaropoulos, Stamatis-Nick Liossis
Expert Opinion on Pharmacotherapy|March 5, 2014
Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatmentsStamatis-Nick C Liossis, Konstantinos Melissaropoulos
Frontiers in Immunology|July 11, 2022
Pathogenetic Aspects of Systemic Sclerosis: A View Through the Prism of B CellsKonstantinos Melissaropoulos, George Iliopoulos, Lazaros I Sakkas, et al.
Mediterranean Journal of Rheumatology|December 29, 2021
Should we be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic DiseasesKalliopi Klavdianou, Konstantinos Melissaropoulos, Alexandra Filippopoulou, et al.
Clinical and Experimental Rheumatology|May 5, 2015
Evolution of undifferentiated arthritis: a ten-year experience from the early arthritis clinic of a tertiary care hospitalGeorgios Yiannopoulos, Dimitrios Daoussis, Konstantinos Melissaropoulos, et al.
Rheumatology International|June 30, 2019
Targeting very early systemic sclerosis: a case-based reviewKonstantinos Melissaropoulos, Pantelis Kraniotis, Dimitrios Bogdanos, et al.
International Journal of Molecular Sciences|May 15, 2020
Rheumatic Manifestations in Patients Treated with Immune Checkpoint InhibitorsKonstantinos Melissaropoulos, Kalliopi Klavdianou, Alexandra Filippopoulou, et al.
Pageof 3